AVITA Medical, Inc. (RCEL) financial statements and ratios from SEC XBRL: revenue $71.61M (TTM), net margin -67.8%, revenue growth 17.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $71.61M |
| Net Margin | -67.8% |
| Revenue Growth (YoY) | 17.8% |
| EPS Growth (YoY) | -34.2% |
| FCF Growth (YoY) | 27.4% |
| Price / Sales | 4.12 |
| FCF Yield | -9.4% |
| Altman Z-Score | -9.40 (distress) |
| Piotroski F-Score | 2/9 |
| Sector P/E (Healthcare) | 21.6 |
RCEL overview · RCEL earnings · RCEL KPIs · RCEL investor relations · RCEL ownership · RCEL peers · RCEL filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.